Bayer Says BlueRock Therapeutics Closes First Cohort in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

(PLX AI) – Bayer says BlueRock Therapeutics announces closeout of first cohort in Phase 1 Trial in patients with Advanced Parkinson’s Disease.BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, …